Recent Updates
Recently added Catalysts
ECOR Positive Sentiment Score: 75/100

electroCore to Present at the Market Movers Investor Summit on May 5, 2026

Key Takeaway: electroCore, Inc. will participate in the Market Movers Investor Summit on May 5, 2026, at the historic Bank of New York. Interim President and CFO Joshua Lev will present and conduct one-on-one meetings. The summit aims to connect company executives with investors, featuring various presentations and networking opportunities.

Market Sentiment Analysis

POSITIVE FACTORS

  • electroCore is actively engaging with investors at a prominent summit.
  • The event provides a platform for networking with executives and fund managers.
  • The company's innovative bioelectronic technologies are highlighted.

Full Press Release Details

ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the Market Movers Investor Summit at the historic Bank of New York. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.

Event Details:

• Date:Tuesday, May 5, 2026
• Company Presentation:12:20 PM ET
• Location:48 Wall Street, New York, NY (The original Bank of New York)
Request an invitation to attend atwww.marketmoverssummit.com.
Summary of Market Movers Investor SummitThe 2026 Market Movers Investor Summit begins on May 4th with a kickoff party at the legendary Delmonico’s, followed by a full day of programming on May 5th. The summit brings together public and private company executives, fund managers, and family offices for a focused, high-caliber experience. The agenda includes company presentations and one-on-one meetings, exclusive fireside chats and keynote sessions, a pop-up lunch from the legendary Katz Delicatessen, and a surprise musical guest.
About electroCore, Inc.electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore®non-invasive vagus nerve stimulation (nVNS) and Quell®neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visitwww.electrocore.com.

Contact:ECOR Investor Relations(973) 302-9253investors@electrocore.com

Frequently Asked Questions

When is the Market Movers Investor Summit?

The summit will take place on May 5, 2026.

Who will represent electroCore at the summit?

Joshua Lev, Interim President and CFO, will represent electroCore.

Where is the Market Movers Investor Summit held?

The event will be held at the historic Bank of New York in New York City.

What is electroCore known for?

electroCore specializes in bioelectronic technologies for health and wellness.

Last updated: Apr 28, 2026